纤维细胞生长因子21的关系,Klotho和糖尿病视网膜病变:一个元分析
Yanhua Jiang1, Weilai Zhang1, Yao Xu2
1Department of Ophthalmology, Fourth People's Hospital of Shenyang, Shenyang, China.
Frontiers in endocrinology
|September 11, 2024
概括
纤维细胞生长因子21 (FGF21) 水平在糖尿病视网膜病变 (DR) 患者中较高,而Klotho水平较低. 了解 FGF21 的理解
科学领域:
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病视网膜病变 (DR) 是糖尿病的一种严重并发症.
- 纤维细胞生长因子21 (FGF21) 和Klotho与DR病原发生有关.
- 关于FGF21和Klotho在DR的确切角色仍在争论中.
研究的目的:
- 在患有糖尿病视网膜病变的患者中定量评估血清FGF21和Klotho水平.
- 为了澄清FGF21,Klotho和DR的存在之间的关联.
主要方法:
- 在主要的科学数据库中进行了全面的文献搜索.
- 对15项研究进行了元分析,使用标准化平均差异 (SMD) 和95%置信区间 (CI).
- 搜索术语包括"糖尿病视网膜病变"",DR"",纤维细胞生长因子21"",FGF21"和"Klotho".
主要成果:
- 与非治疗糖尿病患者相比,DR患者的FGF21水平显著升高 (SMD:2.12,95% CI [1.40,2.84]).
- 与非DR糖尿病患者相比,DR患者的克洛托水平显著下降 (SMD: -0.63,95% CI [-1.22, -0.04]).
结论:
- 这一元分析提供了对FGF21和Klotho在DR中的第一个系统评估.
- 增加的FGF21和减少的Klotho与糖尿病视网膜病变有关.
- 对FGF21作用的进一步研究可能为DR提供新的治疗策略.
相关概念视频
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


